Enveric Biosciences, Inc. (ENVB)
1.41
-0.02
(-1.40%)
USD |
NASDAQ |
Aug 24, 16:00
1.48
+0.07
(+4.96%)
After-Hours: 20:00
Enveric Biosciences Max Drawdown (5Y) : 100.00% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 100.00% |
| June 30, 2026 | 100.00% |
| May 31, 2026 | 100.00% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 100.00% |
| February 28, 2026 | 100.00% |
| January 31, 2026 | 100.00% |
| December 31, 2025 | 100.00% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 99.99% |
| August 31, 2025 | 99.99% |
| July 31, 2025 | 99.99% |
| June 30, 2025 | 99.99% |
| May 31, 2025 | 99.99% |
| April 30, 2025 | 99.99% |
| March 31, 2025 | 99.99% |
| February 28, 2025 | 99.99% |
| January 31, 2025 | 99.99% |
| December 31, 2024 | 99.99% |
| November 30, 2024 | 99.99% |
| October 31, 2024 | 99.99% |
| September 30, 2024 | 99.99% |
| August 31, 2024 | 99.99% |
| July 31, 2024 | 99.99% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.99% |
| May 31, 2024 | 99.99% |
| April 30, 2024 | 99.99% |
| March 31, 2024 | 99.99% |
| February 29, 2024 | 99.99% |
| January 31, 2024 | 99.99% |
| December 31, 2023 | 99.99% |
| November 30, 2023 | 99.99% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.99% |
| March 31, 2023 | 99.99% |
| February 28, 2023 | 99.99% |
| January 31, 2023 | 99.99% |
| December 31, 2022 | 99.99% |
| November 30, 2022 | 99.99% |
| October 31, 2022 | 99.99% |
| September 30, 2022 | 99.99% |
| August 31, 2022 | 99.99% |
| July 31, 2022 | 99.99% |
| June 30, 2022 | 99.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| LENZ Therapeutics, Inc. | 97.31% |
| Impact BioMedical, Inc. | -- |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -98.54 |
| Beta (5Y) | 1.135 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 113.2% |
| Historical Sharpe Ratio (5Y) | -0.7785 |
| Historical Sortino (5Y) | -1.678 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 47.01% |